CaRE2 Monthly Webinar: The Investigation of Oncogenic Signaling Pathways as Potential Drug Targets in Pancreatic Cancer

In celebration of Pancreatic Cancer Awareness Month, our CaRE2 Monthly webinar on November 24 featured one of our Program Steering Committee members, Antonio T. Baines, PhD. Dr. Baines is one of the leading innovators in addressing pancreatic cancer disparities. He is an Associate Professor at the North Carolina Central University Department of Biological and Biomedical Sciences, with a joint appointment at the Julius L. Chambers Biomedical/Biotechnology Institute, as well as an Adjunct Associate Professorship in the Department of Pharmacology at the University of North Carolina School of Medicine. Dr. Baines leads a laboratory dedicated to identifying molecular targets involved in the development of pancreatic cancer cells, exploring the various forces that impact the biology of cancer and health disparities.
For the CaRE2 Monthly Webinar he discussed, “The Investigation of Oncogenic Signaling Pathways as Potential Drug Targets in Pancreatic Cancer.”

Facebook
Twitter
LinkedIn
Pinterest